Soft-tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft-tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phase II Study of Regorafenib as Maintenance Therapy [Phase 2]
Phase II study of regorafenib as maintenance therapy for metastatic soft tissue sarcoma has completed. The trial was sponsored by Centre Osc…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma [Phase 2]
This is a Phase 2 clinical trial update evaluating metformin hydrochloride in combination with standard systemic therapy for previously untr…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY) [Phase 2]
Phase 2 MELODY trial evaluating pegylated liposomal doxorubicin versus active surveillance in adults with advanced soft tissue sarcoma who h…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib in combination with temozolomide for unresectable or metastatic leiomyosarcoma and other soft…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor [Phase 1, Phase 2]
Multicohort Phase 1/2 clinical trial evaluating PM14 as monotherapy and in combination with radiotherapy for soft tissue sarcoma and other s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas [Phase 1, Phase 2]
Phase I/II clinical trial update evaluating LB-100 in combination with doxorubicin versus doxorubicin alone as first-line treatment for adva…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the triple combo of trabectedin, ipilimumab, and nivolumab in previously treated advanced or me…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma [Phase 1]
A Phase 1 study of NOX66 in combination with doxorubicin for anthracycline-naïve adults with metastatic soft-tissue sarcoma was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma [Phase 3]
A phase 3 randomized trial evaluating health-related quality of life in elderly patients with advanced soft tissue sarcoma has been terminat…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating nivolumab with or without ipilimumab in metastatic or unresectable sarcoma shows results from a completed study.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation [Phase 2]
Phase 2 trial update for MORAb-004 in metastatic soft tissue sarcoma with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6) [Phase 3]
The document reports the completion of the Phase 3 SUCCEED trial evaluating ridaforolimus in metastatic soft-tissue sarcoma and metastatic b…